Article
Metformin reveals a mitochondrial copper addiction of mesenchymal cancer cells
6 Nov 2018
Abstract excerpt
The clinically approved drug metformin has been shown to selectively kill persister cancer cells through mechanisms that are not fully understood. To provide further mechanistic insights, we developed a drug surrogate that phenocopies metformin and can be labeled in situ by means of click chemistry. Firstly, we found this molecule to be more potent than metformin in several cancer cell models. Secondly, this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
